All Work

Chris Lange

Why Gilead Sciences Whiffed in Q1

Gilead Sciences released disappointing first-quarter financial results late Tuesday and shares tumbled early Wednesday.

Chris Lange · 8 years ago

Tuesday’s Biggest Winners and Losers in the S&P 500

Tuesday was a mixed day for the broad U.S. markets, although each of the major indices started out the day negative only the Nasdaq and S&P 500 closed up. While most of the market…

Chris Lange · 8 years ago

Facebook Breaks Into Dating: A Bad Break for Match

Match Group, Inc. (NASDAQ: MTCH) and IAC/InterActiveCorp (NASDAQ: IAC) each watched their shares fall off a cliff on Tuesday afternoon, following a big announcement from Facebook, Inc. (NASDAQ: FB). Essentially, Facebook said that it…

Chris Lange · 8 years ago

Why Karyopharm Is on the Move

Karyopharm Therapeutics saw its shares make a handy gain on Tuesday after the firm announced positive top-line results from the Phase 2b STORM study evaluating selinexor.

Chris Lange · 8 years ago

Can Apple Keep Up the Pace With Q2 Earnings?

Apple is scheduled to release its fiscal second-quarter financial results after the markets close on Tuesday and all eyes will be on iPhone sales results.

Chris Lange · 8 years ago

How Keytruda Saved Merck’s Q1

Merck released better-than-expected quarterly results and full-year guidance before the markets opened on Tuesday.

Chris Lange · 8 years ago